BEKYREE Drug Patent Profile
✉ Email this page to a colleague
When do Bekyree patents expire, and what generic alternatives are available?
Bekyree is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in BEKYREE is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bekyree
A generic version of BEKYREE was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BEKYREE?
- What are the global sales for BEKYREE?
- What is Average Wholesale Price for BEKYREE?
Summary for BEKYREE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Patent Applications: | 217 |
| Drug Prices: | Drug price information for BEKYREE |
| DailyMed Link: | BEKYREE at DailyMed |
US Patents and Regulatory Information for BEKYREE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | BEKYREE | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 202226-001 | Aug 12, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
